114 related articles for article (PubMed ID: 36930953)
1. Retrieval of patients with hepatitis C who were lost to follow-up in Southern Denmark.
Dröse S; Hansen JF; Røge BT; Øvrehus ALH; Christensen PB
Infect Dis (Lond); 2023 May; 55(5):361-369. PubMed ID: 36930953
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-up.
Chen CJ; Huang YH; Hsu CW; Chen YC; Chang ML; Lin CY; Shen YH; Chien RN
BMC Gastroenterol; 2023 Feb; 23(1):40. PubMed ID: 36782112
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination.
Isfordink CJ; van Dijk M; Brakenhoff SM; Kracht PAM; Arends JE; de Knegt RJ; van der Valk M; Drenth JPH;
Eur J Intern Med; 2022 Jul; 101():93-97. PubMed ID: 35527178
[TBL] [Abstract][Full Text] [Related]
4. REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.
Kracht PAM; Arends JE; van Erpecum KJ; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Wensing AMJ; Deege MPH; Dimmendaal M; Stadhouders PHGM; Friederich PW; Verhagen MAMT; Boland GJ; Hoepelman AIM
Liver Int; 2019 Mar; 39(3):455-462. PubMed ID: 30204289
[TBL] [Abstract][Full Text] [Related]
5. Retrieval of HCV patients lost to follow-up as a strategy for Hepatitis C Microelimination: results of a Brazilian multicentre study.
Ferraz MLG; de Andrade ARCF; Pereira GHS; Codes L; Bittencourt PL
BMC Infect Dis; 2023 Jul; 23(1):468. PubMed ID: 37442976
[TBL] [Abstract][Full Text] [Related]
6. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.
Isfordink CJ; Boyd A; Sacks-Davis R; van Santen DK; Smit C; Martinello M; Stoove M; Berenguer J; Wittkop L; Klein MB; Rauch A; Salmon D; Lacombe K; Stewart A; Schinkel J; Doyle JS; Hellard M; van der Valk M; Matthews GV;
Lancet Public Health; 2023 Apr; 8(4):e294-e304. PubMed ID: 36965984
[TBL] [Abstract][Full Text] [Related]
7. [Elimination of hepatitis C virus in Denmark].
Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
[TBL] [Abstract][Full Text] [Related]
8. Retrieval and re-evaluation of previously diagnosed chronic hepatitis C infections lost to medical follow-up in the Netherlands.
Heil J; Soufidi K; Stals F; Frantzen H; Robroek-Schaecken A; Bakker CM; van Nunen AB; Dukers-Muijrers NHTM; Hoebe CJPA
Eur J Gastroenterol Hepatol; 2020 Jul; 32(7):851-856. PubMed ID: 31688310
[TBL] [Abstract][Full Text] [Related]
9. Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination.
van Dijk M; Drenth JPH;
J Viral Hepat; 2020 Dec; 27(12):1270-1283. PubMed ID: 32964615
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C.
Isfordink CJ; Brakenhoff SM; van Dijk M; van der Valk M; de Knegt RJ; Arends JE; Drenth JP;
BMJ Open Gastroenterol; 2020; 7(1):e000396. PubMed ID: 32377367
[TBL] [Abstract][Full Text] [Related]
11. Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America.
Mendizabal M; Thompson M; Gonzalez-Ballerga E; Anders M; Castro-Narro GE; Pessoa MG; Cheinquer H; Mezzano G; Palazzo A; Ridruejo E; Descalzi V; Velarde-Ruiz Velasco JA; Marciano S; Muñoz L; Schinoni MI; Poniachik J; Perazzo R; Cerda E; Fuster F; Varon A; Ruiz García S; Soza A; Cabrera C; Gomez-Aldana AJ; Beltrán FM; Gerona S; Cocozzella D; Bessone F; Hernández N; Alonso C; Ferreiro M; Antinucci F; Torre A; Moutinho BD; Coelho Borges S; Gomez F; Murga MD; Piñero F; Sotera GF; Ocampo JA; Cortés Mollinedo VA; Simian D; Silva MO
J Viral Hepat; 2023 Jan; 30(1):56-63. PubMed ID: 36197907
[TBL] [Abstract][Full Text] [Related]
12. A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project.
Dröse S; Øvrehus ALH; Holm DK; Madsen LW; Mössner BK; Søholm J; Hansen JF; Røge BT; Christensen PB
BMC Infect Dis; 2022 Mar; 22(1):202. PubMed ID: 35232372
[TBL] [Abstract][Full Text] [Related]
13. Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence.
Steininger L; Chromy D; Bauer D; Simbrunner B; Binter T; Schwabl P; Schmidbauer C; Trauner M; Gschwantler M; Mandorfer M; Reiberger T
Wien Klin Wochenschr; 2021 May; 133(9-10):452-460. PubMed ID: 33351152
[TBL] [Abstract][Full Text] [Related]
14. Patients with hepatitis C lost to follow-up: ethical-legal aspects and search results.
Andaluz García I; Arcos Rueda MDM; Montero Vega MD; Castillo Grau P; Martín Carbonero L; García-Samaniego Rey J; Romero Portales M; García Sánchez A; Busca Arenzana C; González García J; Montes Ramírez ML; Olveira Martín A
Rev Esp Enferm Dig; 2020 Jul; 112(7):532-537. PubMed ID: 32579001
[TBL] [Abstract][Full Text] [Related]
15. Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study.
McLeod A; Hutchinson SJ; Smith S; Leen C; Clifford S; McAuley A; Wallace LA; Barclay ST; Bramley P; Dillon JF; Fraser A; Gunson RN; Hayes PC; Kennedy N; Peters E; Templeton K; Goldberg DJ
HIV Med; 2021 May; 22(5):334-345. PubMed ID: 33350049
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort.
Bregenzer A; Bruggmann P; Castro E; Moriggia A; Rothen M; Thurnheer MC; Vernazza P; Scheidegger C
Swiss Med Wkly; 2021 Mar; 151():w20460. PubMed ID: 33705563
[TBL] [Abstract][Full Text] [Related]
17. Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.
Marukutira T; Moore KP; Hellard M; Richmond J; Turner K; Pedrana AE; Melody S; Johnston FH; Owen L; Van Den Boom W; Scott N; Thompson A; Iser D; Spelman T; Veitch M; Stoové MA; Doyle J
BMJ Open; 2022 Mar; 12(3):e056120. PubMed ID: 35338062
[TBL] [Abstract][Full Text] [Related]
18. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
[TBL] [Abstract][Full Text] [Related]
19. Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.
Tsertsvadze T; Gamkrelidze A; Chkhartishvili N; Abutidze A; Sharvadze L; Kerashvili V; Butsashvili M; Metreveli D; Gvinjilia L; Shadaker S; Nasrullah M; Adamia E; Zeuzem S; Afdhal N; Arora S; Thornton K; Skaggs B; Kuchuloria T; Lagvilava M; Sergeenko D; Averhoff F
Clin Infect Dis; 2020 Aug; 71(5):1263-1268. PubMed ID: 31563938
[TBL] [Abstract][Full Text] [Related]
20. Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study.
Yen HH; Su PY; Liu II; Zeng YH; Huang SP; Hsu YC; Hsu PK; Chen YY
BMC Gastroenterol; 2021 May; 21(1):209. PubMed ID: 33964873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
